Journal for ImmunoTherapy of Cancer (Nov 2021)
263 ASD141, an innate checkpoint inhibitor, modulates tumor associated myeloid cells through CD11b and enhances current immune checkpoint blockade in preclinical model
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)